Concepedia

Barry S. Orlek

BS

27

Publications

1.1K

Citations

17

H-Index

1975

Active since

Affiliations

New Frontier(Current)

Molecular Discovery (United Kingdom)

University of Oxford

GlaxoSmithKline (United Kingdom)

Barry S. Orlek is an author at New Frontier specializing in pharmacology, medicine, and organic chemistry.

Top concepts

Publications per year

1975–2007

27

Publications

27

Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor

Barry S. Orlek, Frank E. Blaney, Frank Brown et al. · Journal of Medicinal Chemistry · 1991 · 204 citations · Full text

Penicillinase active sites: Labelling of serine‐44 in β‐lactamase I by 6β‐bromopenicillanic acid

V Knott-Hunziker, Stephen G. Waley, Barry S. Orlek et al. · FEBS Letters · 1979 · 129 citations · Full text

, , +10

Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives

Harry J. Wadsworth, S. M. Jenkins, Barry S. Orlek et al. · Journal of Medicinal Chemistry · 1992 · 83 citations · Full text

Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands

S. M. Jenkins, Harry J. Wadsworth, Steven M. Bromidge et al. · Journal of Medicinal Chemistry · 1992 · 73 citations · Full text

, , +11

6 β-Bromopenicillanic acid inactivates β-lactamase I

V Knott-Hunziker, Barry S. Orlek, Peter G. Sammes et al. · Biochemical Journal · 1979 · 73 citations · Full text

, , +17

Rows per page

1–5 of 27